Cure My Disease

Don't miss your cure!

 Log in / Sign up

Dialysis showdown: which method protects heart and bones best?

NCT ID NCT07686978

Not yet recruiting Knowledge-focused Sponsor: Gazi University Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study looks at how different types of dialysis affect heart health, bone metabolism, inflammation, and quality of life in people with end-stage kidney disease. Researchers will compare patients on hemodialysis, continuous ambulatory peritoneal dialysis, and automated peritoneal dialysis, as well as healthy volunteers. No new treatments are given—participants continue their usual care while researchers measure blood markers, artery stiffness, body composition, and symptoms like itching and pain. The goal is to understand which dialysis method may be gentler on the body.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors choose the best dialysis method to reduce heart and bone complications in kidney disease patients.
What could go wrong
This is an observational study, not a treatment trial, so it cannot prove cause and effect. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE KIDNEY DISEASE (ESKD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure sclerosteosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END-STAGE KIDNEY DISEASE (ESKD) HEMODIALYSIS PERITONEAL DIALYSIS (PD)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gazi University Faculty of Medicine, Department of Nephrology

    Ankara, Ankara, 06500, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.